What does Cardiol Therapeutics Inc. do?

Cardiol Therapeutics Inc. is a public company in the Biological Products, (No Diagnostic Substances) industry, incorporated in A6. It is registered with the SEC under CIK 0001702123 and trades on NASDAQ under the ticker CRDL.

How many SEC filings has Cardiol Therapeutics Inc. made?

Cardiol Therapeutics Inc. has filed 157 documents with the SEC since 2017. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Cardiol Therapeutics Inc.

CRDL NASDAQ CIK: 0001702123 Biological Products, (No Diagnostic Substances) Inc. in A6

View on SEC.gov →

Overview All Filings Financials Insiders

Recent Filings

All 157 filings →

Form	Description	Date
6-K	FORM 6-K	Feb 25, 2026
6-K	FORM 6-K	Feb 10, 2026
6-K	FORM 6-K	Feb 2, 2026
SCHEDULE 13G	—	Jan 30, 2026
6-K	FORM 6-K	Jan 26, 2026
6-K	FORM 6-K	Jan 23, 2026
6-K	FORM 6-K	Jan 16, 2026
6-K	FORM 6-K	Jan 13, 2026
6-K	FORM 6-K	Dec 1, 2025
6-K	FORM 6-K	Nov 13, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Cardiol Therapeutics Inc.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001702123
Ticker: CRDL
Exchange: NASDAQ
Incorporated: A6
First Filing: 2017
Total Filings: 157